Arix Bioscience (LSE:ARIX) ROCE % : -2.55% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Arix Bioscience's annualized ROCE % for the quarter that ended in Jun. 2023 was -2.55%.

Arix Bioscience ROCE % Historical Data

The historical data trend for Arix Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience ROCE % Chart

Arix Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-6.58

-5.07

-2.75

-1.53

-2.20

Arix Bioscience Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial								-1.31	-1.84	-1.95	-2.59	-2.55

Arix Bioscience ROCE % Calculation

Arix Bioscience's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-5.293	/	( ( (257.078 - 1.6)	+	(227.847 - 1.923) )	/ 2 )
	=	-5.293	/	( (255.478	+	225.924)	/ 2 )
	=	-5.293	/	240.701
	=	-2.20 %

Arix Bioscience's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-5.918	/	( ( (227.847 - 1.923)	+	(240.534 - 1.414) )	/ 2 )
	=	-5.918	/	( ( 225.924	+	239.12 )	/ 2 )
	=	-5.918	/	232.522
	=	-2.55 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Arix Bioscience (LSE:ARIX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Arix Bioscience ROCE % Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arix Bioscience (LSE:ARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Duke Street, Duke Street House, London, GBR, W1K 6JL

Website

https://www.arixbioscience.com

Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines